751
www.praktickelekarenstvi.cz550715901901162343533734615075796446977287978629369681044111011831228130213851441149115661598162416941761
e3697617148020186176266
PRAKTICKÉ80737159019080160258338422459552632710
LÉKÁRENSTVÍ88197159019074149229330411488590663741833870
AKTUÁLNÍ71882940227122239349476597693822881
FARMAKOTERAPIE81062940227100218330490615733863967106811841312142214781582
Současná5636508018854124196255327385455524
farmakoterapie6187508018852117178273343404470522577639711771799853
benigní7066508018862117189217285356385
hyperplazie7477508018871135195249311371424496555584638
prostaty8141508018860121191247303365412480
dle8647508018869122177
doporučení8851508018868139199270332402461516588617
EAU9494508018854126194
ncbi.nlm.nih.gov/pubmed/18082216.550876015570127196222244313338442464534559626648717785841881948101610861191125413241370142914831546160916681730178518391861
10.5501034015767126151
Roehrborn7291036015564132195263300370440477546
CG,13031036015572147169
et15001036015561100
al.1628103601555782104
The17601036015558128191
effects1979103601556194130190248291339
of23471036015567100
combination24751036015556121227296322390447484510577646
therapy31501036015537105168204262332387
with35661036015591118156224
dutasteride38191036015568135174232278319378415441510572
and44201036015556124194
tamsu‑46421036015564122227273339378
losin550119601552895142167234
on8131196015568137
clinical978119601555883108175200257315341
outcomes13471196015569137176230295401463510
in1885119601552794
men200811960155106168236
with22721196015594120159227
symptomatic25271196015548106212282320385491548585611667
benign32231196015571134202227296364
prostatic36161196015571108174221261319357382439
hyperplasia:40831196015569123194258294365392449495520576596
4-year47071196015563103160220277313
results550135601553899146212237276325
from903135601553675141246
the11781356015542110173
CombAT13791356015576142247317390441
study.1848135601555191159228285300
Eur21771356015563127164
Urol23691356015584120186213
2010;26101356015566126182237258
57:28961356015566125140
123.30651356015566117179200
https://www.ncbi.nlm.nih.gov/pu‑3293135601557210915222226928933637146255965667274279986889491698510101114113612061231129813201389145715131553162016881727
bmed/19825505.5501516015572177239310356414467529588650707768828847
11.5501674015767119138
Karavitakis7161676015561121158216272298337395448476521
M,12661676015597119
et1414167601555997
al.1540167601555581102
Management16701676015598155223280350412516579646683
of2382167601556598
Urinary25091676015577113139207264300361
Retention28981676015562124163222290327353420489
in3415167601552491
Patients35351676015561117155180242310347395
with39591676015590116155223
Benign42101676015562125192217287354
Prostatic4593167601556197163210250308345371427
Obstruction:5501836015587158205245282351407450475543611631
A12091836015577
Systematic13141836015561113160200260365422459485541
Review18841836015566128185211273365
and22781836015559127196
Meta-analysis.250318360155102164202260299356424481507563610635680703
Eur32341836015561126162
Urol34251836015582118184211
2019;36641836015564124180232253
75:39461836015564121139
788.41131836015564123186208
https://www.43501836015570107149220266287334368460557653670
ncbi.nlm.nih.gov/pubmed/30773327.5501996015570127196222244313338443464534559626648717785841881948101610861191125413241370143214941551161216731731178818461854
12.Welk550215401576712314969321560155107165191244
B,965215601556484
et1078215601556099
al.1205215601555783104
The13372156015558129191
risk1556215601553662108160
of17452156015567100
fall1873215601553291117142
and20432156015557125194
fracture2266215601553270128185227295331392
with26862156015592118157225
the29392156015538106168
initiation3136215601552492117156181238275301368437
of36012156015567100
a37292156015557
prostate-selective38152156015572109175222262320358417458505567593655713755781838899
alpha4742215601555783152221278
antagonist:5502316015559126163221290358427451497537559
a11372316015555
population12202316015571141211279304361398423491559
based18072316015568126172234304
cohort21402316015553118187255292335
study.2503231601554484152221277293
BMJ28242316015561160205
2015;30572316015559119175227243
351:33292316015559117170183
h5398.35402316015565126184242304326
https://www.ncbi.nlm.38942316015565102145215261281328363454550647663732789858884906975100011041125
nih.gov/pubmed/26502947.55024760155709516218425332137841848455262272879086090696910281088114812061266133013861394
13.5502634015767123148
Van7262636015564118186
Dijk9412636015581107132185
MM,11542636015598198220
et1402263601556099
al.1529263601555682103
Effects1660263601555890125186244286335
of2024263601556699
alpha(1)-adrenoceptor2151263601555682151220277309365388427484554590651719787845904974101210781115
antagonists32952636015555123160218288356424450495535584
on39072636015566135
male407026360155104161187248
sexual43472636015545107163231288314
functi‑46892636015531100168225267292331
on.5502796015569138159
Drugs7382796015584122190259305
2006;10722796015563123188252271
66:13722796015563127147
287.15472796015564123182189
https://www.ncbi.nlm.nih.gov/pubmed/16526818.17652796015569106149219266286333368460556653670739796865891913982100811121133120312281295131713861454151115511617168517551861192319942039209821522212227023302393244925032525
14.5502954015767125150
Gacci7282956015589147203258283
M,103929560155108131
et11982956015570109
al.1335295601556692113
Impact14762956015535139209268325367
of18712956015576109
medical200929560155113176246272328386412
treatments2449295601554884145201238343406473510559
for30372956015541108145
male321029560155114171197259
lower34972956015535103194255292
urinary38172956015576113139206263300361
tract4206295601554784143200242
symptoms44762956015556113219289327393498544
due5503116015571138199
to7783116015538103
Benign9103116015563125193218287355
prostatic12943116015569106172219259317355380437
hyperplasia17593116015567121193256292363390447493518574
on23623116015567135
ejaculatory2526311601556086142199266292349386451489549
function:31043116015532101168225267293360429449
a35813116015557
systematic36663116015549106154194253358415453478535
review4229311601553696153180241333
and45913116015556124194
me‑481331160155104167207
ta-analysis.550327601554098137194262319345401448473518541
J11193276015545
Sex11933276015560122178
Med139932760155101164235
2014;16623276015563124179234253
11:19433276015564111123
1554.20953276015563115172235255
https://www.ncbi.nlm.nih.gov/pubmed/24708055.23793276015569106149219266286334368460556653670739796866892913982100811121134120312281295131713861454151115511617168617551861192319942040210221582214227223352398245825152535
15.5503434015767123148
Andriole7253436015576144214250277344371433
G,11863436015581104
et13183436015563101
al.1448343601555984106
Dihydrotestosterone158234360155841101782313003364024405005475876526997397998359029701032
and26433436015559126196
the28683436015540108170
prostate:30663436015572109175222262320358417438
the35323436015540108170
scientific37313436015548105130192260297322352384440
rationale4200343601553897134159227296353378440
for46693436015534101138
5al‑48353436015564120145184
phareductase5503596015572140198234294365432489531589635697
inhibitors1276359601552491159184254280319384421469
in1774359601552491
the18943596015537105167
treatment2089359601553774135191228333395463500
of2618359601556699
benign27453596015569132200225294362
prostatic31353596015569106172219259317355380437
hyperplasia.36003596015567121192255292363390446493517574596
J42243596015542
Urol42943596015579115181207
2004;45303596015560121185250269
172:48273596015561111172193
1399.5503756015563115174237254
https://www.ncbi.nlm.nih.gov/pubmed/15371854.8323756015570107150220267287334369461557654671740797866892914983100911131134120412291296131813871455151215521618168617561861192419942040209921512209226523222377243724992520
16.5503914015767126152
Naslund7303916015582139186211278345415
MJ,117339160155100146165
et13663916015562101
al.1495391601555883104
A16283916015574
review1731391601553899156182244336
of20953916015568101
the22243916015539107169
clinical2422391601555682107174199255314339
efficacy2790391601556193126159216274331391
and32093916015558125195
safety34323916015548106139200238298
of37593916015567100
5alpha-reductase38883916015562118144213282339378416476547614671713771817879
inhi‑4796391601552693161186224
bitors550407601557298137202239287
for8664076015534101139
The10334076015561131194
enlarged12554076015564132157214250318380451
prostate.17344076015573110176223263321359418438
Clin22004076015575100125193
Ther24214076015561131194230
2007;26804076015564124188246261
29:29694076015564125146
17.31444076015564114122
https://www.ncbi.nlm.nih.gov/pu‑3294407601557110815022126728833536946155865467174079786789391498310091113113512041229129713181388145615121552161916871726
bmed/17379044.5504236015572177239310356414465526582641705769836856
17.5504394015767122134
McConnell71243960155101159233298367434497523548
JD,12884396015545127145
et14614396015563101
al.1591439601555984106
The17254396015560131193
effect1946439601556397132193251293
of22674396015570103
finasteride2398439601553163130187234274333370396465527
on29544396015569137
the31204396015540108170
risk3319439601553864109162
of35094396015569102
acute36404396015559116183222282
urinary39504396015569105131199256292353
retention4332439601553898137196264301326394463
and48234396015559127196
the5504556015540108170
Need7494556015582144207278
for10554556015533100138
surgical12214556015547114150218243299358383
treatment1633455601553976136192230335397465502
among21634556015558163231300369
men256145560155105167235
with28254556015593119158226
benign30794556015571134202227296364
prostatic34714556015571108174221261319357382439
hyperplasia.39384556015569123194257294365392449495520576598
Finasteri‑4564455601555984152209255295355391418456
de5504716015571133
Long-Term7114716015555122190260299351404441547
Efficacy1286471601555888121154211269326386
and17004716015556124193
Safety19224716015557115148209247307
Study2258471601555793161230287
Group.25734716015578116182250319340
N29414716015580
Engl30494716015558125195220
J32984716015541
Med33684716015598160231
1998;36274716015561113176238258
338:39134716015561119180200
557.41414716015560117176184
https://www.43534716015567104146217263284331365457554650667
ncbi.nlm.nih.gov/pubmed/9475762.550487601557012719622224431333844246453455962664871778584188294810161086119112541324137014311494155116081667172317821802
18.5505034015767125152
Nickel7305036015586111168220281307
JC,10655036015548121142
et12365036015565104
al.1368503601556187108
Comparison15055036015576142247317375412438483552620
of21545036015571104
dutasteride22875036015573139178236283323383419445515577
and28925036015561129199
finasteride3119503601553466133190236277336373399468530
for36785036015536103140
treating3847503601554279139196233258326396
benign42715036015574137205230299367
Prosta‑46675036015567103169215256314353
tic550519601554066122
hyperplasia:7015196015565119191254290361388445491516572592
the13225196015536104166
Enlarged15175196015556123149206242310372443
Prostate1988519601556297163210250308346405
International2422519601552391128187224293350387413480549606632
Comparator30825196015570136241311370406464502567605
Study3715519601555793160230286
(EPICS).4030519601553089151175248308341358
BJU44165196015562105184
Int4629519601552391128
2011;47855196015560120176223235
108:5505356015563118182201
388.7805356015563124187210
https://www.ncbi.nlm.nih.gov/pubmed/21631695.10185356015570107149220266287334368460557653670739796866892913982100811121134120312281296131713861454151115511618168617551861192319942040210221572211227123252379243925002519
19.5505514015767124146
Boyle7245517015568137192219281
P,1033551701556771
et11335517015565103
al.1265551701556186108
Prostate14015517015567103169216256314351411
volume18405517015561128155221326388
predicts22565517015574111172242268324366415
outcome26995517015572139178232298403466
of31935517015571104
treatment3326551701554279139195233337400468504
of38595517015571104
benign39925517015573137204229299366
prostatic43875517015573111177224264322359385441
hy‑48575517015571125163
perplasia5505676015571134170240266323368393448
With102656760155102128167234
finasteride:1288567601552758125181227267326362387456517537
meta-analysis185356760155101163201258297353420476502557604628673
of2554567601556497
randomized2679567601553391158227294399423474533603
clinical3310567601555479103170194250308333
trials.367156760155357297153178223245
Urology39445676015576112177203271341397
1996;43695676015558110172235254
48:46515676015559122142
398.48215676015558116178199
https://www.ncbi.nlm.nih.gov/pubmed/8804493.550583601557010714922026628733436846055765367073979686689291398210081112113412031228129613171387145515111551161816861756186119231994204021002163222622912357241524732493
20.5505994015767131156
Gittelman7345996015588114153196255282386443510
M,127359960155108130
et14325996015570108
al.1569599601556691112
Dutasteride17105996015591159198256303343403439465535596
improves23355996015534138208245311368428475
objective28395996015576147173234292334360417478
and33465996015565133203
subjective35775996015556122192218279337379405462523
disease41295996015577102148210266313375
measures453259960155114176232278345381441488
in550615601552795
men67361560155108170238
With94061560155108135174242
benign12106156015573137204229299366
prostatic16056156015573110176223263321359384441
hyperplasia20746156015571125197260296367394451497522578
and26816156015560128198
modest290761560155108176247309356396
or33326156015570108
severe34686156015550112169230266327
prostate38236156015573111177223264322359419
enlargement.42706156015565133158215251319381486548616653675
J49736156015547
Urol5506316015581117183210
2006;7896316015563123188252271
176:10896316015563114170190
1045.13086316015563118183241260
https://www.ncbi.nlm.nih.gov/pubmed/16890688.15966316015570107150220267287334369461557654670740797866892914983100811131134120412291296131813871455151115521618168617561861192419942040209921532216227723412404246825312553
21.5506474015767126145
Roehrborn7236476015569137200268305375445482551
CG,13026476015577152174
et15046476015566104
al.1637647601556287108
Long-term17746476015561127196265304343402439544
sustained23476476015551117163203261286354416487
improvement28626476015530134204241307364424529591659696
in3587647601552997
symptoms37126476015551109215285323389494540
of42806476015572105
benign44146476015574137205230299367
Pro‑48106476015567103169210
static550663601554889147184210266
hyperplasia8456636015578132203266303374401457504528585
with145866360155103129168236
the17226636015549117179
dual19296636015579146203229
5alpha-reductase21866636015572128154223292349388426487557624681723781828890
inhibitor31046636015536103171196266292331396433
dutasteride:35666636015579146185243289330389426452521583603
results41986636015547107154220245284333
of45596636015578111
4-year46986636015572112169229286322
studies.522087601554889156226251313360382
BJU5631876015565108188
Int584787601552795132
2005;6008876015563123188248265
96:6301876015564127147
572.6477876015563122183203
https://www.ncbi.nlm.nih.gov/pubmed/16104912.6709876015569106149219266286333368460556653670739796865891913982100811121134120312281295131713861454151115511617168517551861192319942039209821522205226023252383243924912511
22.52201034015766131157
Roehrborn54051036015561129192260296366435472541
CG.59741036015570144167
BPH61691036015561125203
progression:64001036015567104170240276336383429453521589608
concept70371036015553118186243302372409
and74751036015554121191
key76941036015550110166
learning7888103601552385141177245270337406
fromMTOPS,8323103601552967133238363422504568626647
ALTESS,89981036015572128178238298355375
COM‑94021036015569150249288
BAT,52201196015567142193207
and54571196015570139210
ALF-ONE.56971196015587145205243335419480502
BJU62291196015577121202
Int64611196015538107145
2008;66361196015574136202267288
101(Suppl.69531196015575131189214271339411484511533
3):75161196015574104124
17.76691196015575127135
https://www.ncbi.nlm.nih.gov/pub‑783411960155811191632352833043533884835816806987698278999269481019104611521175124612721341136414351505156316041672174218141856
med/18307681.522013560155106169239285344398458519577633696752766
23.52201514015767132157
Andriole54051516015584152222259285352379441
GL,58741516015589146169
et60711516015571110
al.6209151601556793114
Effect63511516015569101136197255298
of66771516015577110
dutasteride68161516015578145184242288329388425451520582
on74271516015577145
the76011516015548116178
risk7808151601554672117170
of80061516015578111
prostate81451516015580117183230270328366425
cancer.85991516015566124191248308344360
N89881516015591
Engl91071516015569136205231
J93661516015553
Med944815160155109171242
2010.52201676015563124179234255
362:55031676015564125184204
1192.57361676015563110163221242
https://www.ncbi.nlm.nih.gov/pubmed/20357281.60061676015570107149220266287334368460557653670739796866892913982100811121134120312281296131713871455151115511618168617561861192319942040210221622221227923382399245825142528
24.52201834015767128154
Thompson54021836015559129198303373420488556
IM,59871836015525125147
et61621836015562100
al.6291183601555782103
The64231836015559129191
influence6642183601552693123154221283351408467
of71381836015567100
finasteride7266183601553062129186232273332369395464526
on78211836015567135
the79851836015538106168
development81821836015569131188248275343413519581649686
of88961836015567100
prostate90251836015570107173220260318356415
can‑94691836015556114182221
cer.52201996015558117154170
N54181996015583
Engl55301996015560128197223
J57811996015545
Med585419960155102164235
2003;61171996015564124188247265
349:64101996015564127185207
215.66451996015564119171190
https://www.ncbi.nlm.nih.gov/pubmed/12824459.68641996015569106149219266286333368460556653670739796865891913982100811121134120312281295131713861454151115511617168517551861192319942039209821502209226923242391244825052522
25.52202154015766131155
Baldwin54022156015561119144213305330397
CM,58272156015569168190
et6045215601555896
al.6170215601555479100
Transdermal6298215601555583141208254323384420525582607
oxybutynin.69332156015565117177247315354413482506573595
Drugs,75562156015579116183252298319
2009;79032156015558118182244264
69:81952156015559119140
327.83632156015558115172180
https://www.ncbi.nlm.8571215601556410114321325927932636045154764265972878485387990096899310971118
nih.gov/pubmed/19275276.522023160155709516218425332137841848455262272779086090696510171076113411911250130813641386
26.52202474015767130156
Michel540424760155107133190257319346
MC,577824760155107179201
et60072476015569107
al.6143247601556590111
Does62832476015590159222269
gender65812476015576138206275337374
or69832476015575113
age71242476015565134196
affect7349247601556598133194252294
the76722476015546114176
efficacy78762476015569101134167224282339398
and83032476015565132202
safety85332476015555113146207245305
of88672476015575108
tolterodine?90032476015546111138177236273339410435503565607
J96392476015551
Urol52202636015581117183210
2002;54592636015563123188246266
168:57532636015564118181201
1027.59832636015563118176234241
https://www.ncbi.nlm.nih.gov/pubmed/12187215.62532636015570107149220266287334368460557653670739796866892913982100811121134120312281296131713861455151115511618168617561861192319942040209821502205225923172378243324852505
27.52202794015767129141
Hofner53892796015587155188258320356
K,5774279601556994
et58962796015568106
al.6031279601556389110
Safety61692796015565124156217255315
and65132796015563131201
efficacy6742279601556899132165222280337397
of71672796015574107
tolterodine73022796015545110137176235272338409434501564
extended78942796015568123166226293363425496
release84182796015543103129191247294356
in8802279601553299
men893027960155111173241
with91992796015599125164232
ove‑94592796015574130191231
ractive5220295601553897154196221279340
Bladder5588295601557197154223293355392
symptoms60082956015553111217287325390496542
and65782956015564132201
presumed68082956015576113174221287391454524
non-obstructive73612956015574142211250321392438479515584641683708766827
benign82162956015577140208233302370
prostatic86142956015576114180227267325362388444
hyperplasia.90872956015574128199263299370397454500525581603
World522031160155107171208235304
J55533116015545
Urol56263116015582117183210
2007;58653116015563123188245260
25:61543116015563125142
627.63253116015563122180187
https://www.ncbi.nlm.nih.gov/pubmed/17906864.65413116015570107149219266287334368460557653670739796866892913982100811121134120312281296131713861454151115511618168617561861192319942040209821492208227223352398246125272547
28.52203274015767131158
Kaplan54063276015575134204231288356
SA,57903276015570143166
et59853276015572111
al.6124327601556994115
Tolterodine62683276015570129156195255291357428453521583
extended68793276015573129171231299368430501
release74093276015547108134196252298360
attenuates77983276015568106148208276343400437497544
lower83703276015537105197258295
urinary86933276015579115141209266302363
tract9084327601555087145202244
symp‑93573276015558115222291333
toms52203436015540106211257
in5506343601552997
Men563134360155104166234
with58943436015596122161229
benign61523436015574137205230299367
prostatic65473436015575112178225265323361386443
hyperplasia.70183436015572126198261297368395452498523579601
J76483436015547
Urol77243436015584119186212
2005;79653436015566126191251268
174:82613436015566117170190
2273.84793436015566128186246267
https://www.ncbi.87743436015573109152222269289337371463560656673742799869895916
nlm.nih.gov/pubmed/16280803.5220359601557095199221290315383405474542598638705773843948101110811127118612401299135814211484154716061626
29.52203754015767131153
Roehrborn54013756015566135198266302373442480549
CG,59783756015574149171
et61783756015563101
al.6308375601555985106
Effects6442375601556193128189247290338
of68093756015569102
serum69403756015548110147215320
PSA72883756015566124197
on75133756015570138
efficacy7680375601556394127160217276332392
of81013756015569102
tolterodine82313756015541106133172231268334405430497559
extended88193756015563119162221289359421491
release9339375601553899125187243289351
with52203916015594120159227
or54753916015568106
without56093916015593119158226294362401
tamsulosin6038391601553997202248314340407454479546
in6613391601552693
men673439160155106168236
with69983916015593119158226
LUTS,72523916015558133194254275
including7555391601552694151176243312338405475
OAB.80583916015586157221243
Urology83293916015580116182209277348404
2008;87623916015562122187250270
72:90603916015562123144
1061.92323916015562117181234248
htt‑95083916015569106148182
ps://www.ncbi.nlm.nih.gov/pubmed/18817961.52204076015572119139186220312409505522591648718744765835860964986105510801148116912391307136314031470153816081713177518461892195020042067212321742233229623492363
30.52204234015767131157
Gacci54054236015581139196250275
M,570942360155100123
et58604236015563101
al.5990423601555884105
A61234236015576
systematic62274236015549107154194254358416453479535
review6791423601553798155181243335
and71544236015559126196
meta-analysis737942360155105168206264303360428485511567614639684
on80924236015568137
the82584236015539107169
use84564236015568114176
of86614236015568101
phosphodiestera‑87914236015571140208255324393461532557619666706765802860900
se52204396015548111
553594396015565
inhibitors5452439601552996164189259285324389427474
alone5955439601556086154222285
or62684396015571108
in6404439601552996
combination65294396015559125230300326393450488513581650
with72074396015595121160228
alpha-blockers7464439601556086155224281320392419487545597658694742
for82354396015535102139
lower8403439601552997189250286
urinary87184396015570106133200257293354
tract9101439601554178137194236
symp‑93654396015550108214284325
toms52204556015540106211257
due55064556015579146208
to57424556015549115
benign58854556015581144212237306374
prostatic62874556015581118184231271329366392448
hyperplasia.67644556015578132203267303374401458504529585607
Eur74004556015569134170
Urol75984556015591126193219
2012;78464556015572132188240260
61:81344556015572125137
994.83004556015572135199219
https://www.ncbi.nlm.85474556015579116158229275296343377469566662679748805875901922992101711211143
nih.gov/pubmed/22405510.522047160155709516218425332137841848455262272779086090696810301086115012111268132213771397
31.52204874015766126146
Wang539548760155103160228299
Y,5723487601556275
et5828487601555999
al.5956487601555683105
Tadalafil60904876015558107177235262320351382408
565284876015560
mg661848760155103173
Once68214876015584154211272
Daily71224876015581139165191249
Improves74004876015524129200238306363424472
Lower79024876015555122215277314
Urinary82464876015578115142210268306367
Tract8643487601555786146204247
Symptoms89194876015557111217288327394500547
and94954876015556125195
Erectile5220503601556198159218262289315378
Dysfunction:56285036015581141189225295364422466493562631652
A63105036015573
Systematic64135036015561115163205266372430469495553
Review69965036015563126184212275368
and73945036015556125196
Meta-analysis.76205036015598161201260301359428486513571619645692716
Lower83655036015555123216279316
urinary87115036015566104131200258296358
tract9099503601553775135193236
symp‑93655036015546105212283325
toms52205196015540107214261
2018.55115196015565126183239262
10:58035196015565121144
84.59775196015564131152
https://www.ncbi.nlm.nih.gov/pubmed/293415.6159519601557110915322527329434337947257066868675681488591393510061033113811611232125813271350142014901547158916571726179719041967203920872150221222712335238924432463
32.52205354015767128155
Porst54035356015574139177224265
H,56965356015591112
et58365356015572110
al.5975535601556793114
Efficacy6118535601556999132165222280337397
and65435356015568135205
safety67775356015557115148209247307
of71135356015578111
tadalafil72525356015549107177234259316346377403
576835356015572
mg778453560155115184
once79975356015578146203262
daily82885356015579136161187243
for85595356015543110147
lower87355356015536104196257293
urinary90575356015577114140207264301361
tract9447535601554985144201243
Symptoms52205516015560112219288326392497543
suggestive57925516015546112182252314361401426484545
of63655516015567100
benign64945516015569133200225295362
prostatic68855516015569107173220260318355381437
hyperplasia:73515516015567121193256292363390447493518574594
subgroup79745516015546112182253289355423493
analyses84955516015557125182208264311373420
of89445516015567100
pooled90725516015570139209235297368
data94685516015569126163222
from5220567601553472139244
454935676015573
multinational,559456760155116183209247273340397435460528597654680700
randomized,63225676015548106174244312417443494554625646
placebo-controlled69965676015581108165222282352421462522588656693730797823849910981
clinical8006567601556793117185210267325351
studies.8385567601555898166236261323370392
Urology88065676015590126193219287358415
2013;92495676015573134189241260
82:95375676015573132153
667.52205836015563127185192
https://www.ncbi.nlm.nih.gov/pubmed/23876588.54415836015569106149219266286334368460556653670739796866892913982100811121134120312281295131713861454151115511617168517551860192319932039210121632224228223382398245925212544
33.52205994015767129154
Casabe54025996015574132179237307371
A,5801599601557599
et59285996015563101
al.6058599601555884105
Efficacy6191599601556091124157214272329388
and66085996015558126195
safety68325996015548107139200238299
of71595996015569102
the72895996015539108170
coadministration74875996015557123181251356381448473519559596654692717785853
of83695996015568101
tadalafil8499599601553997167224250307337368393
once89215996015568137194253
daily92035996015570127152177233
with94655996015593119158226
Finasteride5220615601556085152209255295355391417486548
for5797615601552996133
659596156015559
months604661560155102171239276344390
in6464615601552390
men658261560155102165232
with68436156015589115154222
lower7093615601552391183244280
urinary74026156015564101127194251287348
tract7778615601553673131188230
symptoms80366156015545102208278316381486532
and85976156015554122191
prostatic88176156015567104170217257315352378434
Enlarge‑92806156015556123148205241309371410
ment522063160155106169237274
secondary55226316015553115173239308377434471531
to60826316015545110
benign62216316015576140207233302369
prostatic66196316015576114180227267325362388444
hyperplasia.70926316015574128199263299370397454500525581603
J77246316015549
Urol78026316015586122188215
2014;80456316015568129184239258
191:83316316015568121177189
727.85496316015568129187194
https://www.ncbi.87726316015574111154224271291339373465561658675744801871897918
nlm.nih.gov/pubmed/24096118.5220647601557095199221290315383405474542598638705773843948101110811127118912451309137214351487153515891611
34.52206634015766131156
Andersson54036636015571137206266302349394461528
KE.59596636015559119140
On61276636015581149
the63036636015535102163
Site6494663601555578116174
and66966636015554120188
Mechanism69126636015595156213279335402426470573
of7512663601556496
Action76366636015570125166190257324
of7988663601556395
beta3-Adrenoceptor811166360155661281662232833193924594945536206877448028709089721008
Agonists91476636015570137204271295340379427
in9601663601552389